Jump to content

Jane Visvader

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by BG19bot (talk | contribs) at 07:35, 15 October 2016 (WP:CHECKWIKI error fix for #61. Punctuation goes before References. Do general fixes if a problem exists. -). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Jane Visvader

Professor Jane Visvader is a scientist specialising in breast cancer research who works for the Walter and Eliza Hall Institute in Melbourne, Australia. She is the joint head of the Breast Cancer Laboratory with Professor Geoff Lindeman.[1] In 2008, Jane Visvader was a joint recipient of the GlaxoSmithKline Award for Research Excellence [2] for outstanding contribution to Breast Cancer research. Professor Visvader was made a fellow of the Australian Academy of Science in 2012.[3] Professor Visvader's most recent award is the 2014 Royal Society of Victoria Research Medal for Scientific Excellence in Biomedical & Health Sciences.[4]

Education and career

Professor Visvader holds a PhD in Biochemistry from the University of Adelaide having studied structure and function of citrus exocortis viroid[5] and has undertaken postdoctoral studies in the Verma Laboratory (Salk Institute, San Diego) and Adams Laboratory (Walter and Eliza Hall Institute (WEHI)). She has also worked at the Children's Hospital/Harvard Medical School in Boston before returning to Victoria in 1997 to establish a Breast Cancer Laboratory at WEHI.[6] She was awarded a fellowship of the Australian Academy of Health and Medical Sciences in October 2016.[7]

Research

Professor Visvader has published work considering the role of Cells of Origin in Cancer [8] and in particular focuses on the role of stem cells [9][10] which she believes may be a key to understanding breast cancer.[11]

Patents

Prof. Visvader is a named inventor on five patents relating to cancer research focused on stem cell isolation and diagnostics.[12]

  • Method Of Cell Isolation, Application number: 20080038230
  • Differentiation and/or proliferation modulating agents and uses therefor, Application number: 20060166917
  • Novel phosphoprotein, Application number: 20060148032
  • Method of diagnosis and treatment and agents useful for same, Application number: 20050048528
  • Differentiation and/or proliferation modulating agents and uses therefor, Application number: 20030175971

References

  1. ^ "Professor Jane Visvader". Retrieved 2014-08-14.
  2. ^ "Latest News - Walter and Eliza Hall Institute of Medical Research". Retrieved 2014-08-14.
  3. ^ "Fellowship list - Australian Academy of Science". Science.org.au. Retrieved 2014-08-14.
  4. ^ "News | Royal Society of Victoria | Promoting Science and Science Education". Royalsocietyvictoria.org.au. Retrieved 2014-08-14.
  5. ^ "Structure and function of citrus exocortis viroid / by Jane Ellen Visvader. - Version details - Trove". Trove.nla.gov.au. Retrieved 2014-08-14.
  6. ^ "News | Royal Society of Victoria | Promoting Science and Science Education". Royalsocietyvictoria.org.au. Retrieved 2014-08-14.
  7. ^ "AAHMS announces its second scientific meeting and induction of new fellows" (PDF). Australian Academy of Health and Medical Sciences. Retrieved 14 October 2016.
  8. ^ http://www.nature.com/nature/journal/v469/n7330/full/nature09781.html
  9. ^ http://www.nature.com/nature/journal/v506/n7488/full/nature12948.html
  10. ^ http://www.cell.com/cell-stem-cell/abstract/S1934-5909%2812%2900240-8
  11. ^ Giovanni Valenti (2012-01-11). "Interview with Jane Visvader: stem cells in the breast | Europe's stem cell hub". EuroStemCell. doi:10.1038/nature04372. Retrieved 2014-08-14.
  12. ^ "Patents by Inventor Jane Visvader - Justia Patents Database". Patents.justia.com. Retrieved 2014-08-14.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Jane_Visvader&oldid=744443182"